Biography: Dr. Damjan Glavač earned his PhD from the University of Ljubljana, Slovenia, where he currently serves as Head of the Department of Molecular Genetics at the Faculty of Medicine and Professor of Human Genetics.
His research focuses on the genetic analysis of disease-associated genes involved in hereditary disorders and cancer. Dr. Glavač has authored over 190 peer-reviewed scientific publications, in addition to 15 invited articles, 2 invited editorials, 12 book chapters, more than 50 contributions to international conferences, and over 30 invited lectures.
A key aspect of his work includes the translation of research findings and emerging technologies into clinical practice. This has led to improvements in risk prediction, targeted screening, prevention, and treatment strategies for several hereditary diseases, including multiple endocrine neoplasia type 2, Lynch syndrome, and Alport syndrome, Amyotrophic lateral sclerosis (ALS), Spinal Muscular Atrophy (SMA) and many others
Dr. Glavač is the founder and president of the Slovenian Society of Human Genetics (since 2005) and a founding member of the Human Genome Variation Society.